Suppr超能文献

抗生素对颌骨骨坏死中细菌谱的影响。

Antibiotic effects on bacterial profile in osteonecrosis of the jaw.

机构信息

Department of Chemical and Biological Sciences, Polytechnic Institute of New York University, USA.

出版信息

Oral Dis. 2012 Jan;18(1):85-95. doi: 10.1111/j.1601-0825.2011.01848.x. Epub 2011 Aug 29.

Abstract

OBJECTIVE

Oral infection is considered to play a critical role in the pathogenesis of bisphosphonate-related osteonecrosis of the jaw (BRONJ), and antibiotic therapy has become a mainstay of BRONJ therapy. This study was aimed to investigate the effect of antibiotics on bacterial diversity in BRONJ tissues.

MATERIALS AND METHODS

The bacterial profile from soft tissues associated with the BRONJ lesion was determined using 16S rRNA-based denaturing gradient gel electrophoresis (DGGE) and sequencing. Twenty BRONJ subjects classified as stage 0-2 were enrolled in this study, and patient groups were divided into an antibiotic cohort (n=10) treated with systemic antibiotic and a non-antibiotic cohort (n=10) with no prior antibiotic therapy.

RESULTS

The DGGE fingerprints indicated no significant differences in bacterial diversity of BRONJ tissue samples. Patients on antibiotics had higher relative abundance of phylum Firmicutes with bacterial species, Streptococcus intermedius, Lactobacillus gasseri, Mogibacterium timidum, and Solobacterium moorei, whereas patients without antibiotics had greater amounts of Parvimonas micra and Streptococcus anginosus. Thirty percent of bacterial populations were uncultured (yet-to be cultured) phylotypes.

CONCLUSION

This study using limited sample size indicated that oral antibiotic therapy may have a limited efficacy on the bacterial population associated with BRONJ lesions.

摘要

目的

口腔感染被认为在双膦酸盐相关性颌骨骨坏死(BRONJ)的发病机制中起关键作用,抗生素治疗已成为 BRONJ 治疗的主要方法。本研究旨在探讨抗生素对 BRONJ 组织中细菌多样性的影响。

材料和方法

采用基于 16S rRNA 的变性梯度凝胶电泳(DGGE)和测序技术,确定与 BRONJ 病变相关的软组织中的细菌谱。本研究纳入了 20 名 BRONJ 患者(分期为 0-2 期),将患者分为抗生素组(n=10)和非抗生素组(n=10),抗生素组接受全身抗生素治疗,非抗生素组未接受过抗生素治疗。

结果

DGGE 指纹图谱表明 BRONJ 组织样本的细菌多样性无显著差异。使用抗生素的患者中厚壁菌门的相对丰度较高,细菌种类包括中间链球菌、加氏乳杆菌、迟缓真杆菌和摩氏摩根菌,而未使用抗生素的患者中普氏微菌和咽峡炎链球菌的数量较多。30%的细菌种群为未培养(尚未培养)的分类群。

结论

本研究使用有限的样本量表明,口腔抗生素治疗对 BRONJ 病变相关的细菌种群可能疗效有限。

相似文献

1
Antibiotic effects on bacterial profile in osteonecrosis of the jaw.
Oral Dis. 2012 Jan;18(1):85-95. doi: 10.1111/j.1601-0825.2011.01848.x. Epub 2011 Aug 29.
2
Molecular profiling of oral microbiota in jawbone samples of bisphosphonate-related osteonecrosis of the jaw.
Oral Dis. 2012 Sep;18(6):602-12. doi: 10.1111/j.1601-0825.2012.01916.x. Epub 2012 Mar 23.
3
Oral microbiota and host innate immune response in bisphosphonate-related osteonecrosis of the jaw.
Int J Oral Sci. 2014 Dec;6(4):219-26. doi: 10.1038/ijos.2014.46. Epub 2014 Aug 8.
4
Microbial population changes in patients with medication-related osteonecrosis of the jaw treated with systemic antibiotics.
Oral Surg Oral Med Oral Pathol Oral Radiol. 2018 Mar;125(3):268-275. doi: 10.1016/j.oooo.2017.11.022. Epub 2017 Dec 11.
6
Metagenomic investigation of microbes and viruses in patients with jaw osteonecrosis associated with bisphosphonate therapy.
Oral Surg Oral Med Oral Pathol Oral Radiol. 2012 Dec;114(6):764-70. doi: 10.1016/j.oooo.2012.08.444.
7
[Bisphosphonate related osteonecrosis of the jaw and infection with Actinomyces].
Med Clin (Barc). 2012 Dec 15;139(15):676-80. doi: 10.1016/j.medcli.2012.05.039. Epub 2012 Oct 25.
8
Clinical experience with spiramycin in bisphosphonate-associated osteonecrosis of the jaw.
Int J Immunopathol Pharmacol. 2010 Apr-Jun;23(2):619-26. doi: 10.1177/039463201002300224.
9
Clinical treatment outcomes for 40 patients with bisphosphonates-related osteonecrosis of the jaws.
J Formos Med Assoc. 2014 Mar;113(3):166-72. doi: 10.1016/j.jfma.2012.04.010. Epub 2012 Jul 31.

引用本文的文献

1
Chinese expert consensus on the diagnosis and clinical management of medication-related osteonecrosis of the jaw.
J Bone Oncol. 2024 Nov 19;49:100650. doi: 10.1016/j.jbo.2024.100650. eCollection 2024 Dec.
5
Mechanistic advances in osteoporosis and anti-osteoporosis therapies.
MedComm (2020). 2023 May 11;4(3):e244. doi: 10.1002/mco2.244. eCollection 2023 Jun.
6
9
, and promote IL8/IFNγ/TNFα-based pro-inflammation in patients with medication-related osteonecrosis of the jaw.
J Oral Microbiol. 2020 Nov 23;13(1):1851112. doi: 10.1080/20002297.2020.1851112.
10
Age-Associated Tooth Loss and Oral Microbial Dysbiosis in a Mouse Genetic Model of Chronic Nicotine Exposure.
Front Immunol. 2020 Oct 7;11:575200. doi: 10.3389/fimmu.2020.575200. eCollection 2020.

本文引用的文献

1
WITHDRAWN: Bisphosphonates promote jaw osteonecrosis through facilitating bacterial colonisation.
Med Hypotheses. 2011 Aug;77(2):214-5. doi: 10.1016/j.mehy.2011.04.015. Epub 2011 May 13.
4
Microbial diversity in saliva of oral squamous cell carcinoma.
FEMS Immunol Med Microbiol. 2011 Apr;61(3):269-77. doi: 10.1111/j.1574-695X.2010.00773.x. Epub 2011 Feb 1.
5
Osteonecrosis of the jaw and the role of macrophages.
J Natl Cancer Inst. 2011 Feb 2;103(3):232-40. doi: 10.1093/jnci/djq516. Epub 2010 Dec 28.
6
Relevance of a prolonged preoperative antibiotic regime in the treatment of bisphosphonate-related osteonecrosis of the jaw.
J Oral Maxillofac Surg. 2011 Feb;69(2):362-80. doi: 10.1016/j.joms.2010.06.200. Epub 2010 Dec 3.
7
Fluorescence-guided bone resection in bisphosphonate-related osteonecrosis of the jaws: first clinical results of a prospective pilot study.
J Oral Maxillofac Surg. 2011 Jan;69(1):84-91. doi: 10.1016/j.joms.2010.07.014. Epub 2010 Oct 25.
8
Bisphosphonate-related osteonecrosis of the jaw: an overview.
Ann N Y Acad Sci. 2011 Feb;1218:38-46. doi: 10.1111/j.1749-6632.2010.05768.x. Epub 2010 Sep 28.
9
In vivo effects of zoledronic acid on oral mucosal epithelial cells.
Oral Dis. 2011 Apr;17(3):291-7. doi: 10.1111/j.1601-0825.2010.01739.x. Epub 2010 Sep 23.
10
The role of microbial biofilms in osteonecrosis of the jaw associated with bisphosphonate therapy.
Curr Osteoporos Rep. 2010 Mar;8(1):40-8. doi: 10.1007/s11914-010-0008-1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验